Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Nanometrics Reports First Quarter 2018 Financial Results: Record Revenues, Gross Margin and Earnings; Outlook Strengthens for FY 2018

Abstract:
Nanometrics Incorporated (NASDAQ:NANO), a leading provider of advanced process control systems, today announced financial results for its first quarter ended March 31, 2018.

Nanometrics Reports First Quarter 2018 Financial Results: Record Revenues, Gross Margin and Earnings; Outlook Strengthens for FY 2018

Milpitas, CA | Posted on May 1st, 2018

First Quarter 2018 Highlights:

Record Financial Results. Strong positions with key customers and a continued positive business environment, particularly for memory, helped drive record revenues, gross margin, and earnings per share. Revenues of $82.3 million were up 39% from the first quarter of 2017, and up 5% from the fourth quarter of 2017. Record gross margin was higher than forecast, due to the greater revenue volume and an increased contribution of high-margin upgrades, as well as a favorable accrual adjustment.

Significant Competitive Wins and Increasing Market Share. The company recently announced two significant competitive wins: the selection of the IMPULSE®+ integrated metrology platform by a leading-edge DRAM manufacturer, and the adoption of Nanometrics’ broad portfolio of fab-wide process control solutions by a domestic China 3D-NAND manufacturer. Both of these new positions resulted in increased market share, stronger revenues for the first quarter, and are also contributing to the company’s strengthened outlook for the full year 2018.

Strong Free Cash Flow Generation. The company reported $32.7 million in cash flow from operating activities, and after capital expenditures of $1.3 million, generated a record $31.4 million in free cash flow. Total cash, cash equivalents and marketable securities increased $6.9 million quarter-over-quarter, after $23.0 million of stock repurchases, to end the quarter with a balance of $123.9 million.

Completion of $50 Million Stock Repurchase Program. Nanometrics completed the $50 million stock repurchase program announced last November, buying back just under two million shares over the last two quarters at an average price of $25.48 per share.

GAAP Results
Q1 2018 Q4 2017 QoQ Q1 2017 YoY
Revenues (Millions) $ 82.3 $ 78.2 5% $ 59.3 39%
Gross Margin 57.7% 56.2% 150 bps 48.0% 970 bps
Operating Margin 25.0% 24.5% 50 bps 9.3% 1570 bps
Net Income (Millions) $ 16.4 $ 10.8 52% $ 5.4 206%
Earnings per Diluted Share $ 0.67 $ 0.42 60% $ 0.21 223%

Non-GAAP Results
Q1 2018 Q4 2017 QoQ Q1 2017 YoY
Gross Margin 57.8% 56.4% 140 bps 48.3% 950 bps
Operating Margin 25.6% 25.3% 30 bps 9.9% 1570 bps
Net Income (Millions) $ 16.5 $ 13.6 22% $ 4.8 245%
Earnings per Diluted Share $ 0.67 $ 0.53 28% $ 0.19 264%

A reconciliation between GAAP operating results and non-GAAP operating results is provided following the financial statements that are part of this release and on the investor page of Nanometrics' website. Non-GAAP results exclude the impact of amortization of acquired intangibles, severance costs, executive transition and search costs and certain discrete tax items.

“We are very pleased to report stronger-than-expected financial results for the first quarter, in which we achieved new records in revenue, gross margin, earnings per share, and free cash flow,” commented Dr. Pierre-Yves Lesaicherre, president and chief executive officer of Nanometrics. “Our first-quarter revenues reflected both the strength of the capital spending environment for memory devices, as well as our recently-announced significant market share wins, which were immediately impactful to our product sales. Customer demand from both the NAND and DRAM market segments is reflecting that our customers’ ramp in investments is both faster and stronger than we previously forecast, improving our results for the first quarter as well as our outlook for the full year. Further, our results demonstrate that we are executing well toward our financial model targets. While there were a couple of key factors driving our gross margin outperformance that were unique to the first quarter, normalized margins of approximately 56% for the period indicate the company is ahead of schedule in achieving its gross margin targets.

“Our outlook for 2018 has strengthened since last quarter, both in terms of revenue growth and profitability. Our greater market share, higher revenue volume, and increased gross margin are enabling us to make investments in R&D and our global sales organization in support of future growth, while delivering strong profits and cash flows.” Dr. Lesaicherre concluded, “2018 is off to a very strong start, and we are looking forward to delivering a fifth straight year of double-digit revenue growth, with expanding gross and operating margins, increased earnings per share, and significant free cash flow generation. As we invest in new technologies, we are also excited to deliver on our R&D investments, and introduce new products to drive continued growth and outperformance in the years to come.”

First Quarter 2018 Summary
Revenues for the first quarter of 2018 were $82.3 million, up 5.3% from $78.2 million in the fourth quarter of 2017, and up 38.8% from $59.3 million in the first quarter of 2017. On a GAAP basis, gross margin was 57.7%, compared to 56.2% in the prior quarter and 48.0% in the year-ago period. Operating income was $20.6 million, compared to $19.2 million in the prior quarter and $5.5 million in the year-ago period. Net income was $16.4 million or $0.67 per diluted share, compared to $10.8 million or $0.42 per diluted share in the prior quarter and $5.4 million or $0.21 per diluted share in the first quarter of 2017.

On a non-GAAP basis, which excludes amortization of acquired intangible assets and severance included in cost of revenues, gross margin was 57.8%, compared to 56.4% in the prior quarter and 48.3% in the year-ago period. Non-GAAP operating income also excludes severance included in operating expenses, and executive search and transition costs, and was $21.0 million, compared to $19.8 million in the prior quarter and $5.8 million in the first quarter of 2017. Non-GAAP net income also adjusts for certain discrete tax items and the tax effect of non-GAAP adjustments and was $16.5 million or $0.67 per diluted share, compared to $13.6 million or $0.53 per diluted share in the prior quarter and $4.8 million or $0.19 per diluted share in the first quarter of 2017.

Business Outlook
Management expects second quarter 2018 revenues in the range of $82 to $90 million. Gross margin is expected to be approximately 56%, plus or minus 1%, on both a GAAP and non-GAAP basis. Management expects second-quarter operating expenses to range between $27.0 million and $28.0 million on both a GAAP and non-GAAP basis, and earnings in the range of $0.57 to $0.74 per diluted share on both a GAAP and non-GAAP basis. The earnings per share guidance reflects an improved tax rate of 22% to 23%, compared to the 25% estimate previously in guidance.

Conference Call Details
A conference call to discuss first quarter 2018 results will be held today at 4:30 p.m. EDT (1:30 p.m. PDT). To participate in the conference call, the dial-in numbers are (877) 374-4041 for domestic callers and (253) 237-1156 for international callers. The conference ID is 4785405. A live and recorded webcast and supplemental financial information will be made available on the investor page of the Nanometrics website at www.nanometrics.com.

Use of Non-GAAP Financial Information
The non-GAAP gross profit, gross margin, operating income, operating income margin, net income, net income per share, which exclude certain expenses, charges and special items, and free cash flow, were not prepared in accordance with U.S. Generally Accepted Accounting Principles (GAAP). Management uses non-GAAP financial results, which exclude amortization of acquired intangibles assets, severance costs, executive transition and search costs, and certain discrete tax items, to evaluate the company’s ongoing performance and to enable comparison to other periods that did not include these items. The company believes the presentation of non-GAAP results is useful to investors for analyzing ongoing business trends, comparing performance to prior periods, and enhancing the investor’s ability to view the company’s results from management’s perspective; however, investors are cautioned that other companies may calculate these measures differently than Nanometrics does, which would limit the usefulness of these financial measures. A table presenting a reconciliation of GAAP results to non-GAAP results is included at the end of this press release and is available on the investor page of the Nanometrics website at www.nanometrics.com.

####

About Nanometrics Incorporated
Nanometrics is a leading provider of advanced, high-performance process control metrology and inspection systems used primarily in the fabrication of semiconductors and other solid-state devices, including sensors, optoelectronic devices, high-brightness LEDs, discretes and data storage components. Nanometrics’ automated and integrated metrology systems measure critical dimensions, device structures, topography and various thin film properties, including three-dimensional features and film thickness, as well as optical, electrical and material properties. The company’s process control solutions are deployed throughout the fabrication process, from front-end-of-line substrate manufacturing, to high-volume production of semiconductors and other devices, to advanced three-dimensional wafer-level packaging applications. Nanometrics’ systems enable advanced process control for device manufacturers, providing improved device yield at reduced manufacturing cycle time, supporting the accelerated product life cycles in the semiconductor and other advanced device markets. The company maintains its headquarters in Milpitas, California, with sales and service offices worldwide. Nanometrics is traded on Nasdaq Global Select Market under the symbol NANO. Nanometrics’ website is http://www.nanometrics.com.

Forward Looking Statements
Certain statements in this press release, including those found in Dr. Lesaicherre’s quote, under the caption “Business Outlook,” and elsewhere regarding expected future financial performance, are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those described in this release. Although Nanometrics believes that the expectations reflected in the forward-looking statements are reasonable, actual results could differ materially from these expectations due to a variety of factors, including, but not limited to: decreased levels of industry spending; slowing adoption rate of Nanometrics’ new product; Nanometrics’ inability to gain additional market share, increase sales, ship products as scheduled, achieve customer acceptance of new products or outperform the industry; decreased demand for Nanometrics’ products; shifts in the timing of customer orders and product shipments; technology adoption rates; changes in customer and product mix; changes in market share; changes in operating expenses; and general economic conditions. For additional information and considerations regarding the risks faced by Nanometrics that could cause actual results to differ materially, see its annual report on Form 10-K for the year ended December 30, 2017, as filed with the Securities and Exchange Commission on February 26, 2018 including under the caption “Risk Factors,” as well as other periodic reports filed with the SEC from time to time. Nanometrics disclaims any obligation to update information contained in any forward-looking statement, except as required by law.


NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

March 31,
2018 December 30,
2017
ASSETS
Current assets:
Cash and cash equivalents $ 65,912 $ 34,899
Marketable securities 57,975 82,130
Accounts receivable, net 59,034 62,457
Inventories 53,110 52,860
Inventories-delivered systems 1,493 1,534
Prepaid expenses and other 6,905 6,234
Total current assets 244,429 240,114

Property, plant and equipment, net 43,795 44,810
Goodwill 10,611 10,232
Intangible assets, net 3,171 2,206
Deferred income tax assets 9,671 11,924
Other assets 345 413
Total assets $ 312,022 $ 309,699

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable $ 18,492 $ 13,857
Accrued payroll and related expenses 9,669 12,901
Deferred revenue 9,029 7,408
Other current liabilities 7,120 7,249
Income taxes payable 3,565 2,680
Total current liabilities 47,875 44,095

Deferred revenue 1,290 1,661
Income taxes payable 1,409 860
Deferred tax liabilities 186 179
Other long-term liabilities 535 521
Total liabilities 51,295 47,316

Stockholders’ equity:
Common stock 24 26
Additional paid-in capital 234,793 255,368
Retained earnings 26,136 9,113
Accumulated other comprehensive income (loss) (226 ) (2,124 )
Total stockholders’ equity 260,727 262,383
Total liabilities and stockholders’ equity $ 312,022 $ 309,699




NANOMETRICS INCORPORATED
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands except per share amounts)
(Unaudited)

Three Months Ended
March 31, 2018 April 1, 2017

Net revenues:
Products $ 71,019 $ 48,175
Service 11,294 11,139
Total net revenues 82,313 59,314

Costs of net revenues:
Cost of products 28,593 25,478
Cost of service 6,154 5,337
Amortization of intangible assets 35 52
Total costs of net revenues 34,782 30,867
Gross profit 47,531 28,447


Operating expenses:
Research and development 10,202 8,694
Selling 9,024 7,938
General and administrative 7,741 6,307
Amortization of intangible assets - -
Total operating expenses 26,967 22,939
Income from operations 20,564 5,508

Other income (expense):
Interest income 3 1
Interest expense (96 ) (40 )
Other income, net 352 (3 )
Total other income (expense), net 259 (42 )

Income before income taxes 20,823 5,466
Provision for income taxes 4,442 114
Net income $ 16,381 $ 5,352

Net income per share:
Basic $ 0.68 $ 0.21
Diluted

For more information, please click here

Copyright © Nanometrics Incorporated

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Researchers develop artificial building blocks of life March 8th, 2024

How surface roughness influences the adhesion of soft materials: Research team discovers universal mechanism that leads to adhesion hysteresis in soft materials March 8th, 2024

Two-dimensional bimetallic selenium-containing metal-organic frameworks and their calcinated derivatives as electrocatalysts for overall water splitting March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

Chip Technology

New chip opens door to AI computing at light speed February 16th, 2024

HKUST researchers develop new integration technique for efficient coupling of III-V and silicon February 16th, 2024

Electrons screen against conductivity-killer in organic semiconductors: The discovery is the first step towards creating effective organic semiconductors, which use significantly less water and energy, and produce far less waste than their inorganic counterparts February 16th, 2024

NRL discovers two-dimensional waveguides February 16th, 2024

Announcements

What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024

Curcumin nanoemulsion is tested for treatment of intestinal inflammation: A formulation developed by Brazilian researchers proved effective in tests involving mice March 8th, 2024

The Access to Advanced Health Institute receives up to $12.7 million to develop novel nanoalum adjuvant formulation for better protection against tuberculosis and pandemic influenza March 8th, 2024

Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024

Tools

First direct imaging of small noble gas clusters at room temperature: Novel opportunities in quantum technology and condensed matter physics opened by noble gas atoms confined between graphene layers January 12th, 2024

New laser setup probes metamaterial structures with ultrafast pulses: The technique could speed up the development of acoustic lenses, impact-resistant films, and other futuristic materials November 17th, 2023

Ferroelectrically modulate the Fermi level of graphene oxide to enhance SERS response November 3rd, 2023

The USTC realizes In situ electron paramagnetic resonance spectroscopy using single nanodiamond sensors November 3rd, 2023

Financial Reports

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Second Quarter Results April 16th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project